Raal, Frederick J.

Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION ‐9, ORION ‐10 and ORION ‐11 Phase 3 randomized trials

Leiter, L. A., Raal, F. J., Schwartz, G. G., Koenig, W., Ray, K. K., Landmesser, U., Han, J., Conde, L. G., & Wright, R. S. (2024) · Diabetes, Obesity and Metabolism

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 27

Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease

Wright, R. S., Ray, K. K., Landmesser, U., Koenig, W., Raal, F. J., Leiter, L. A., Conde, L. G., Han, J., & Schwartz, G. G. (2024) · Mayo Clinic Proceedings

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 25

Safety and efficacy of inclisiran in South African patients at high cardiovascular risk: A subanalysis of the ORION phase III clinical trials

Carbohydrate and Lipid Metabolism Research Unit, F. O. H. S., Raal, F., Ableson, M., Vergelegen Mediclinic, S. W., Blignaut, S., Paarl Research Centre, P., Burgess, L., Tread Research, C. U., Coetzer, S., Accelerated Enrollment Solutions, H. C. R. C., et al. (2022) · South African Medical Journal

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 14

Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

Koenig, W., Ray, K. K., Kallend, D. G., Landmesser, U., Leiter, L. A., Schwartz, G. G., Wright, R. S., Garcia Conde, L., Jaros, M., & Raal, F. J. (2021) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 3